{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:23:41Z","timestamp":1788920621661,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.schres.2008.12.012","type":"journal-article","created":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T20:04:35Z","timestamp":1232568275000},"page":"127-133","source":"Crossref","is-referenced-by-count":99,"title":["Insulin resistance and secretion in vivo: Effects of different antipsychotics in an animal model"],"prefix":"10.1016","volume":"108","author":[{"given":"Araba F.","family":"Chintoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve W.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loretta","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adria","family":"Giacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Nobrega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Remington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.schres.2008.12.012_bib1","doi-asserted-by":"crossref","first-page":"862","DOI":"10.2337\/diabetes.54.3.862","article-title":"Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs","volume":"54","author":"Ader","year":"2005","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.schres.2008.12.012_bib2","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychotic-induced weight gain: a comprehensive research synthesis","volume":"156","author":"Allison","year":"1999","journal-title":"Am. J. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2008.12.012_bib3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejphar.2008.06.105","article-title":"The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063","volume":"592","author":"Assie","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.schres.2008.12.012_bib4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0006-8993(02)03616-8","article-title":"Comparative effects of the antipsychotics sulpiride or risperidone in rats. I: bodyweight, food intake, body composition, hormones and glucose tolerance","volume":"957","author":"Baptista","year":"2002","journal-title":"Brain Res."},{"issue":"8","key":"10.1016\/j.schres.2008.12.012_bib5","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.pnpbp.2004.08.001","article-title":"Comparative effects of the antipsychotics sulpiride and risperidone in female rats on energy balance, body composition, fat morphology and macronutrient selection","volume":"28","author":"Baptista","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.schres.2008.12.012_bib6","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.lfs.2007.08.009","article-title":"Effect of chronic infusion of olanzapine and clozapine on food intake and body weight gain in male and female rats","volume":"81","author":"Choi","year":"2007","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.schres.2008.12.012_bib7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0026-0495(91)90057-4","article-title":"Bromocriptine inhibits the seasonally occurring obesity, hyperinsulinemia, insulin resistance, and impaired glucose tolerance in the Syrian hamster, Mesocricetus auratus","volume":"40","author":"Cincotta","year":"1991","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.schres.2008.12.012_bib8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hup.868","article-title":"HTR2C haplotypes and antipsychotic-induced weight gain: X-linked multimarker analysis","volume":"22","author":"De Luca","year":"2007","journal-title":"Hum. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.schres.2008.12.012_bib9","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2337\/diacare.19.3.278","article-title":"In praise of the hyperglycemic clamp. A method for assessment of beta-cell sensitivity and insulin resistance","volume":"19","author":"Elahi","year":"1996","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.schres.2008.12.012_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1017\/S1461145704004171","article-title":"Evidence-based pharmacotherapy of schizophrenia","volume":"7","author":"Emsley","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2008.12.012_bib11","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2337\/diab.36.8.914","article-title":"Estimation of endogenous glucose production during hyperinsulinemic\u2013euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates","volume":"36","author":"Finegood","year":"1987","journal-title":"Diabetes"},{"issue":"Suppl 1","key":"10.1016\/j.schres.2008.12.012_bib12","first-page":"32","article-title":"Prolactin-related and metabolic adverse effects of atypical antipsychotic agents","volume":"69","author":"Henderson","year":"2008","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2008.12.012_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.62.1.19","article-title":"Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis","volume":"62","author":"Henderson","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2008.12.012_bib14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.npp.1301209","article-title":"Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects","volume":"32","author":"Houseknecht","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"5\u20136","key":"10.1016\/j.schres.2008.12.012_bib15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000095339","article-title":"Increased susceptibility to diet-induced obesity in histamine-deficient mice","volume":"83","author":"Jorgensen","year":"2006","journal-title":"Neuroendocrinology"},{"issue":"9","key":"10.1016\/j.schres.2008.12.012_bib16","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1176\/ajp.151.9.1395a","article-title":"Severe hyperglycemia associated with high doses of clozapine","volume":"151","author":"Kamran","year":"1994","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2008.12.012_bib17","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1176\/ajp.153.4.466","article-title":"Serotonin\u2013dopamine interaction and its relevance to schizophrenia","volume":"153","author":"Kapur","year":"1996","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2008.12.012_bib18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.schres.2008.12.012_bib19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.physbeh.2005.10.007","article-title":"The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight","volume":"87","author":"King","year":"2006","journal-title":"Physiol. Behav."},{"issue":"10","key":"10.1016\/j.schres.2008.12.012_bib20","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1176\/ajp.151.10.1520b","article-title":"Diabetic ketoacidosis associated with clozapine treatment","volume":"151","author":"Koval","year":"1994","journal-title":"Am. J. Psychiatry"},{"issue":"7\u20138","key":"10.1016\/j.schres.2008.12.012_bib21","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.neuropharm.2006.07.006","article-title":"Distinct endocrine effects of chronic haloperidol or risperidone administration in male rats","volume":"51","author":"Lin","year":"2006","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.schres.2008.12.012_bib22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00002018-199309060-00005","article-title":"Adverse effects of antipsychotic drugs","volume":"9","author":"Malhotra","year":"1993","journal-title":"Drug Safety"},{"issue":"1","key":"10.1016\/j.schres.2008.12.012_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajmg.b.30115","article-title":"Clozapine-induced weight gain associated with the 5HT2C receptor \u2212759C\/T polymorphism","volume":"133B","author":"Miller","year":"2005","journal-title":"Am. J. Med. Genet. B. Neuropsychiatr. Genet."},{"issue":"Suppl 1","key":"10.1016\/j.schres.2008.12.012_bib24","first-page":"1","article-title":"Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review","volume":"19","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"issue":"10","key":"10.1016\/j.schres.2008.12.012_bib25","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/2647","article-title":"Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene","volume":"4","author":"Nonogaki","year":"1998","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.schres.2008.12.012_bib26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00004850-200503000-00007","article-title":"The effect of betahistine, a histamine H1 receptor agonist\/H3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenia patients","volume":"20","author":"Poyurovsky","year":"2005","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.schres.2008.12.012_bib27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1034\/j.1600-0447.2002.2c257a.x","article-title":"Olanzapine-induced destabilization of diabetes in the absence of weight gain","volume":"105","author":"Ramankutty","year":"2002","journal-title":"Acta Psychiatr. Scand."},{"issue":"7","key":"10.1016\/j.schres.2008.12.012_bib28","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2165\/00002018-200730070-00004","article-title":"Risk of diabetic ketoacidosis after exposure to risperidone or olanzapine","volume":"30","author":"Ramaswamy","year":"2007","journal-title":"Drug Safety"},{"issue":"Suppl 10","key":"10.1016\/j.schres.2008.12.012_bib29","first-page":"5","article-title":"Receptor pharmacology of neuroleptics: relation to clinical effects","volume":"60","author":"Richelson","year":"1999","journal-title":"J Clin. Psychiatry"},{"issue":"44","key":"10.1016\/j.schres.2008.12.012_bib30","doi-asserted-by":"crossref","first-page":"36824","DOI":"10.1074\/jbc.M505560200","article-title":"Dopamine D2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion","volume":"280","author":"Rubi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.schres.2008.12.012_bib31","doi-asserted-by":"crossref","unstructured":"Savoy, Y.E., Ashton, M.A., Miller, M.W., Nedza, F.M., Spracklin, D.K., Hawthorn, M.H., Rollema, H., Matos, F.F., Hajos-Korcsok, E., in press. Differential effects of various typical and atypical antipsychotics on plasma glucose and insulin levels in the mouse: evidence for the involvement of sympathetic regulation. Schizophr. Bull. [14 Aug 2008 Electronic publication ahead of print].","DOI":"10.1093\/schbul\/sbn104"},{"issue":"5","key":"10.1016\/j.schres.2008.12.012_bib32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1358\/mf.2005.27.5.908643","article-title":"Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes","volume":"27","author":"Silvestre","year":"2005","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.schres.2008.12.012_bib33","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0021-9258(19)77804-1","article-title":"Rates of glucose production and oxidation in normal and diabetic rats","volume":"192","author":"Stetten","year":"1951","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.schres.2008.12.012_bib34","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1210\/jcem.87.6.8578","article-title":"Comparison of insulin sensitivity, clearance and secretion estimates using euglycemic and hyperglycemic clamps","volume":"87","author":"Uwaifo","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.schres.2008.12.012_bib35","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4088\/JCP.v60n0602","article-title":"Novel antipsychotics: comparison of weight gain liabilities","volume":"60","author":"Wirshing","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2008.12.012_bib36","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1192\/bjp.187.6.537","article-title":"Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol","volume":"187","author":"Zipursky","year":"2005","journal-title":"Br. J. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996408005574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996408005574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T09:42:03Z","timestamp":1709977323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996408005574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":36,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0920996408005574"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2008.12.012","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}